Qiagen NVQGEN
▼ ネガティブ規制関連度
Qiagen subsidiary Parse Biosciences ordered to pay $4.8M for infringing patents, with injunction and enhanced damages sought.
銘柄への影響 3
Biotech & Genomic Medicine
Qiagen NV
10X Genomics IncTXG
▲ ポジティブ規制関連度
Jury affirmed validity of patents licensed by 10x Genomics' Scale Biosciences unit and awarded damages, strengthening its IP position.
Health Care
Roche Holding AGROP
▲ ポジティブ規制関連度
Roche-licensed patents were upheld as valid and infringed, benefiting its patent licensing position.
テーマインパクト
カバレッジ外企業 2
Parse Biosciences非上場▼ ネガティブ
規制関連度
Parse Biosciences hit with $4.8M jury award for patent infringement and faces possible injunction.
Scale Biosciences非上場▲ ポジティブ
規制関連度
Scale Biosciences' licensed patents were affirmed valid and infringed, supporting its patent enforcement.